1921
Volume 77, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

We undertook active population-based surveillance in 5,000 urban households among children < 5 years old to determine invasive pneumococcal disease (IPD) incidence, serotype distribution, clinical presentation, and antimicrobial resistance, which have not been previously described in population-based studies from the region. IPD was documented by blood culture isolation. From 01 April 2004 to 31 March 2006, 5,903 blood cultures were collected from 6,167 eligible children. was isolated from 34 pneumococcal patients; IPD was clinically associated with pneumonia (24%), upper respiratory infection (62%), and febrile syndromes (14%). Overall, IPD and 13-valent serotype–related IPD incidences were 447 and 276 episodes/100,000 child-years, respectively. Peak IPD incidence occurred during the cool dry seasons. Penicillin, cotrimoxazole, chloramphenicol, and ciprofloxacin resistances were 2.9%, 82.4%, 14.7%, and 24.1%, respectively. Current conjugate vaccines should substantially reduce IPD, childhood pneumonia, and antimicrobial resistance in Bangladesh.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2007.77.795
2007-11-01
2017-09-20
Loading full text...

Full text loading...

/deliver/fulltext/14761645/77/5/0770795.html?itemId=/content/journals/10.4269/ajtmh.2007.77.795&mimeType=html&fmt=ahah

References

  1. Bryce J, Boschi-Pinto C, Shibuya K, Black RE, 2005. WHO estimates of the causes of death in children. Lancet 365 : 1147–1152.
  2. Greenwood B, 1999. The epidemiology of pneumococcal infection in children in the developing world. Philos Trans R Soc Lond B Biol Sci 354 : 777–785.
  3. Baqui AH, Sabir AA, Begum N, Arifeen SE, Mitra SN, Black RE, 2001. Causes of childhood deaths in Bangladesh: an update. Acta Paediatr 90 : 682–690.
  4. Arifeen SE, Akhter T, Chowdhury HR, Rahman KM, Chowdhury EK, 2005. Causes of death in children under five years of age. Bangladesh Demographic and Health Survey 2004. Dhaka: National Institute of Population Research and Training, 125–133.
  5. Williams BG, Gouws E, Boschi-Pinto C, Bryce J, Dye C, 2002. Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet 2 : 25–32.
  6. Rudan I, Tomaskovic L, Boschi-Pinto C, Campbell H, 2004. Global estimate of the incidence of clinical pneumonia among children under five years of age. Bull WHO 82 : 895–903.
  7. Farha T, Thomson AH, 2005. The burden of pneumonia in children in the developed world. Paediatr Respir Rev 6 : 76–82.
  8. Brooks WA, Santosham M, Naheed A, Goswami D, Wahed MA, Diener-West M, Faruque AS, Black RE, 2005. Effect of weekly zinc supplements on incidence of pneumonia and diarrhoea in children younger than 2 years in an urban, low-income population in Bangladesh: randomised controlled trial. Lancet 366 : 999–1004.
  9. Cutts FT, Zaman SM, Enwere G, Jaffar S, Levine OS, Okoko JB, Oluwalana C, Vaughan A, Obaro SK, Leach A, McAdam KP, Biney E, Saaka M, Onwuchekwa U, Yallop F, Pierce NF, Greenwood BM, Adegbola RA, 2005. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 365 : 1139–1146.
  10. Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N, 2003. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 349 : 1341–1348.
  11. O’Brien KL, Moulton LH, Reid R, Weatherholtz R, Oski J, Brown L, Kumar G, Parkinson A, Hu D, Hackell J, Chang I, Kohberger R, Siber G, Santosham M, 2003. Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial. Lancet 362 : 355–361.
  12. Saha SK, Baqui AH, Darmstadt GL, Ruhulamin M, Hanif M, El Arifeen S, Santosham M, Oishi K, Nagatake T, Black RE, 2003. Comparison of antibiotic resistance and serotype composition of carriage and invasive pneumococci among Bangladeshi children: implications for treatment policy and vaccine formulation. J Clin Microbiol 41 : 5582–5587.
  13. World Health Organization, Department of Child and Adolescent Health and Development, and UNICEF, 2000. Management of the Child With a Serious Infection or Severe Malnutrition: Guidelines for Care at the First-Referral Level in Developing Countries. Geneva: Department of Child and Adolescent Health and Development UNICEF.
  14. Saha SK, Rikitomi N, Biswas D, Watanabe K, Ruhulamin M, Ahmed K, Hanif M, Matsumoto K, Sack RB, Nagatake T, 1997. Serotypes of Streptococcus pneumoniae causing invasive childhood infections in Bangladesh, 1992 to 1995. J Clin Microbiol 35 : 785–787.
  15. NCCLS, 2002. Performance of Standards for Antimicrobial Susceptibility Testing: Twelfth Informational Supplement. Villanova, PA: NCCLS.
  16. Jorgensen JH, Howell AW, Maher LA, 1991. Quantitative antimicrobial susceptibility testing of Haemophilus influenzae and Streptococcus pneumoniae by using the E-test. J Clin Microbiol 29 : 109–114.
  17. Brooks WA, Hossain A, Goswami D, Nahar K, Alam K, Ahmed N, Naheed A, Nair GB, Luby S, Breiman RF, 2005. Bacteremic typhoid fever in children in an urban slum, Bangladesh. Emerg Infect Dis 11 : 326–329.
  18. StataCorp, 2006. Stata Statistical Software SE: Release 9.2. College Station, TX: Stata Corporation.
  19. Herz AM, Greenhow TL, Alcantara J, Hansen J, Baxter RP, Black SB, Shinefield HR, 2006. Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine. Pediatr Infect Dis J 25 : 293–300.
  20. 1999. Prospective multicentre hospital surveillance of Streptococcus pneumoniae disease in India. Invasive Bacterial Infection Surveillance (IBIS) Group, International Clinical Epidemiology Network (INCLEN). Lancet 353 : 1216–1221.
  21. Brent AJ, Ahmed I, Ndiritu M, Lewa P, Ngetsa C, Lowe B, Bauni E, English M, Berkley JA, Scott JA, 2006. Incidence of clinically significant bacteraemia in children who present to hospital in Kenya: community-based observational study. Lancet 367 : 482–488.
  22. Ulloa-Gutierrez R, Avila-Aguero ML, Herrera ML, Herrera JF, Arguedas A, 2003. Invasive pneumococcal disease in Costa Rican children: a seven year survey. Pediatr Infect Dis J 22 : 1069–1074.
  23. Lagos R, Munoz A, Valenzuela MT, Heitmann I, Levine MM, 2002. Population-based surveillance for hospitalized and ambulatory pediatric invasive pneumococcal disease in Santiago, Chile. Pediatr Infect Dis J 21 : 1115–1123.
  24. UNICEF/WHO, 2006. Pneumonia: The Forgotten Killer of Children. New York: The United Nations Children’s Fund/World Health Organization.
  25. Lanata CF, Rudan I, Boschi-Pinto C, Tomaskovic L, Cherian T, Weber M, Campbell H, 2004. Methodological and quality issues in epidemiological studies of acute lower respiratory infections in children in developing countries. Int J Epidemiol 33 : 1362–1372.
  26. Hill Z, Kendall C, Arthur P, Kirkwood B, Adjei E, 2003. Recognizing childhood illnesses and their traditional explanations: exploring options for care-seeking interventions in the context of the IMCI strategy in rural Ghana. Trop Med Int Health 8 : 668–676.
  27. Mandell LA, Peterson LR, Wise R, Hooper D, Low DE, Schaad UB, Klugman KP, Courvalin P, 2002. The battle against emerging antibiotic resistance: should fluoroquinolones be used to treat children? Clin Infect Dis 35 : 721–727.
  28. Pelton SI, 2005. Otitis media: re-evaluation of diagnosis and treatment in the era of antimicrobial resistance, pneumococcal conjugate vaccine, and evolving morbidity. Pediatr Clin North Am 52 : 711–728.
  29. Schrag S, Bealle B, Dowell S, 2001. Resistant Pneumococcal Infections: the Burden of Disease and Challenges in Monitoring and Controlling Antimicrobial Resistance. Geneva, Switzerland: World Health Organization.
  30. Shahid NS, Steinhoff MC, Hoque SS, Begum T, Thompson C, Siber GR, 1995. Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine. Lancet 346 : 1252–1257.
  31. Saha SK, Rikitomi N, Ruhulamin M, Masaki H, Hanif M, Islam M, Watanabe K, Ahmed K, Matsumoto K, Sack RB, Nagatake T, 1999. Antimicrobial resistance and serotype distribution of Streptococcus pneumoniae strains causing childhood infections in Bangladesh, 1993 to 1997. J Clin Microbiol 37 : 798–800.
  32. Hausdorff WP, 2002. Invasive pneumococcal disease in children: geographic and temporal variations in incidence and serotype distribution. Eur J Pediatr 161 (Suppl 2): S135–S139.
  33. Adegbola RA, Secka O, Lahai G, Lloyd-Evans N, Njie A, Usen S, Oluwalana C, Obaro S, Weber M, Corrah T, Mulholland K, McAdam K, Greenwood B, Milligan PJ, 2005. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. Lancet 366 : 144–150.
  34. Lagos R, Levine OS, Avendano A, Horwitz I, Levine MM, 1998. The introduction of routine Haemophilus influenzae type b conjugate vaccine in Chile: a framework for evaluating new vaccines in newly industrializing countries. Pediatr Infect Dis J 17 (9 Suppl): S139–S148.
  35. Gessner BD, Sutanto A, Linehan M, Djelantik IG, Fletcher T, Gerudug IK, Ingerani, Mercer D, Moniaga V, Moulton LH, Moulton LH, Mulholland K, Nelson C, Soemohardjo S, Steinhoff M, Widjaya A, Stoeckel P, Maynard J, Arjoso S, 2005. Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial. Lancet 365 : 43–52.
  36. Mulholland EK, Adegbola RA, 1998. The Gambian Haemophilus influenzae type b vaccine trial: what does it tell us about the burden of Haemophilus influenzae type b disease? Pediatr Infect Dis J 17 (9 Suppl): S123–S125.
  37. Mulholland EK, 2004. Use of vaccine trials to estimate burden of disease. J Health Popul Nutr 22 : 257–267.
  38. Saha SK, Darmstadt GL, Yamanaka N, Billal DS, Nasreen T, Islam M, Hamer DH, 2005. Rapid diagnosis of pneumococcal meningitis: implications for treatment and measuring disease burden. Pediatr Infect Dis J 24 : 1093–1098.
  39. Buckingham SC, McCullers JA, Lujan-Zilbermann J, Knapp KM, Orman KL, English BK, 2001. Pneumococcal meningitis in children: relationship of antibiotic resistance to clinical characteristics and outcomes. Pediatr Infect Dis J 20 : 837–843.
  40. Campbell JD, Kotloff KL, Sow SO, Tapia M, Keita MM, Keita T, Diallo S, Hormazabal JC, Murray P, Levine MM, 2004. Invasive pneumococcal infections among hospitalized children in Bamako, Mali. Pediatr Infect Dis J 23 : 642–649.
  41. Castaneda E, Penuela I, Vela MC, Tomasz A, 1998. Penicillin-resistant Streptococcus pneumoniae in Colombia: presence of international epidemic clones. Colombian pneumococcal study group. Microb Drug Resist 4 : 233–239.
  42. Hausdorff WP, Yothers G, Dagan R, Kilpi T, Pelton SI, Cohen R, Jacobs MR, Kaplan SL, Levy C, Lopez EL, Mason EO Jr, Syriopoulou V, Wynne B, Bryant J, 2002. Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr Infect Dis J 21 : 1008–1016.
  43. Kyaw MH, Clarke S, Edwards GF, Jones IG, Campbell H, 2000. Serotypes/groups distribution and antimicrobial resistance of invasive pneumococcal isolates: implications for vaccine strategies. Epidemiol Infect 125 : 561–572.
  44. Kaplan SL, Mason EO Jr, Wald E, Tan TQ, Schutze GE, Bradley JS, Givner LB, Kim KS, Yogev R, Barson WJ, 2002. Six year multicenter surveillance of invasive pneumococcal infections in children. Pediatr Infect Dis J 21 : 141–147.
  45. Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Rein-gold A, Thomas AR, Harrison LH, Bennett NM, Farley MM, Facklam RR, Jorgensen JH, Besser J, Zell ER, Schuchat A, Whitney CG, 2006. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 354 : 1455–1463.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2007.77.795
Loading
/content/journals/10.4269/ajtmh.2007.77.795
Loading

Data & Media loading...

  • Received : 21 Jan 2007
  • Accepted : 19 Jul 2007

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error